Supportive principles in the pharmacological management of the patients with epilepsy

Background: Pharmacological management of patients with epilepsy is still a very challenging approach for the best outcome of these patients. When considering the appropriate treatment choice for patients it is necessary to take into account several factors that can influence the effectiveness and q...

Full description

Bibliographic Details
Main Authors: Oleg Cobileanschi, Elena Condratiuc, Ion Cazacu, Diana Popusoi
Format: Article
Language:English
Published: Scientific Medical Association of Moldova 2018-12-01
Series:The Moldovan Medical Journal
Subjects:
Online Access:http://moldmedjournal.md/wp-content/uploads/2018/12/moldmedjournal-2018-61-4-cobileanschi-et-al-full-text.pdf
Description
Summary:Background: Pharmacological management of patients with epilepsy is still a very challenging approach for the best outcome of these patients. When considering the appropriate treatment choice for patients it is necessary to take into account several factors that can influence the effectiveness and quality of life. Cancelling or changing treatment suddenly can lead to uncontrolled seizures. After a short period without seizures, many patients are tempted to abandon treatment. Cessation of treatment can be discussed after a seizure-free period for at least two years. Treatment should be discontinued gradually by reducing the dosage and constant supervision of the physician. This paper analyses briefly the general pharmacological and treatment methods in several forms of adult epilepsy. Conclusions: Management of epilepsy means more than observing the medication prescribed by the specialist. It is also important for the patient to maintain his general health status, monitor the symptoms of epilepsy and response to treatment and take care of his safety. Involvement in the management of one’s own affection can help the patient to control his condition and to continue his routine in usual manner. The objective of antiepileptic treatment is to reduce epileptic seizures to zero without intolerable side effects. New treatments should focus not only on reducing the frequency and intensity of seizures but also improving the quality of life of patients.
ISSN:2537-6373
2537-6381